[1]袁志斌.核医学影像诊断多发性骨髓瘤的临床价值[J].国际放射医学核医学杂志,2003,27(4):162-164.
　YUAN Zhi-bin.The clinical value of radionulide scintigraphy in the assessing of multiple myeloma[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):162-164.
点击复制

核医学影像诊断多发性骨髓瘤的临床价值(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
27
期数:
2003年第4期
页码:
162-164
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The clinical value of radionulide scintigraphy in the assessing of multiple myeloma
作者:
袁志斌
200233 上海, 上海交通大学附属第六人民医院核医学科
Author(s):
YUAN Zhi-bin
Shanghai, Jiaotong University, Department of Nuclear Medicine, Shanghai 6th People’s Hospital, Shanghai 200233, China
关键词:
多发性骨髓瘤; 18F-氟代脱氧葡萄糖; 99Tcm-甲氧基异丁基异腈; 铊-201; 放射免疫显像
Keywords:
multiple myeloma; 18F-fluoro-deoxyglucose; 99Tcm-seatamibi; 201Tl; radioimmunoscintigraphy
分类号:
R817.4
摘要:
核医学影像检查,包括18F-FDG(18F-氟代脱氧葡萄糖)、99Tcm-MIBl(99cm-甲氧基异丁基异腈)、201Tl、标记抗体和其他多种显像剂,对诊断多发性骨髓瘤有一定价值,是X线摄片、CT和MRI等其他影像学检查有益的补充。核医学影像检查可以了解全身骨骼的状况,用于疾病的分期和判断疗效,但仍需结合其他检查提高诊断的准确率。
Abstract:
Nuclear medicine imaging modalities,including 18F-FDG,99Tcm-MIBI,201Tl,radionuclide labeled antibody and other radioagent,had got certain value in detecting multiple myeloma.These methods were useful com plement of planar X photo,CT and MRI.Radionuclide scintigraphy can demonstrate the condition of whole body bone,stage of the disease and follow up the therapy result,but it needs other examinations to increase its diagnosis accuracy.

参考文献/References:

[1] Schirrmeister H, Bommer M, Buck AK, et al. Initial results in the assessment of multiple myeloma using 18F-FDG PET[J]. Eur J Nucl Med, 2002, 29(3): 361-366.
[2] EI-Shirbiny AM, Yeung H, Imbriaco M, et al. Technetium 99m-MIBI versus fluorine-18 FDG in diffuse multiple myeloma[J]. J Nucl Med, 1997, 38(8): 1208-1210.
[3] Orchard K, Barrington S, Buscombe J, et al. Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma[J]. Br J Hematol, 2002, 117(1): 133-135.
[4] Pace L, Catalano L, Del Vecchio S, et al. Predictive value of technetium-99m seatamibi in patients with multiple myeloma and potential role in the follow-up[J]. Eur J Nucl Med,2001, 28(3): 304-312.
[5] Alexandrakis MG, Kyriakou DS, Passam F, et al. Value of Tc-99m seatamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate[J]. Ann hematol, 2001, 80(6): 349-353.
[6] Watanabe N, Shimizu M, Kageyama M, et al. Multiple myelomaevaluated with 201Tl scintigraphy compared with bone scintigraphy[J]. J Nucl Med, 1999, 40(7): 1138-1142.
[7] Ishibashi M, Nonoshita M, Uchida M, et al. Bone marrow uptake of thallium-201 before and after therapy in multiple myeloma[J]. J Nucl Med, 1998, 39(3): 473-475.
[8] Sohn SK, Ahn BC, Lee SW, et al. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma[J]. Eur J Nucl Med, 2002, 29(5): 591-596.

相似文献/References:

[1]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
　CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):10.
[2]陈香,赵军.PET-CT在非小细胞肺癌中的应用[J].国际放射医学核医学杂志,2005,29(3):97.
　CHEN Xiang,ZHAO Jun.The application value of PET-CT imaging in non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):97.
[3]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
　JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):197.
[4]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
　CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):201.
[5]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
　WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):205.
[6]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
　DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):209.
[7]刘建军,黄钢.18F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究[J].国际放射医学核医学杂志,2005,29(5):213.
　LIU Jian-jun,HUANG Gang.Application study of 18F-FDG PET and PET-CT on malignant bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):213.
[8]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216.
　HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):216.
[9]黄建敏,付占立,潘莉萍.18F-FDG代谢显像标准摄取值的影响因素[J].国际放射医学核医学杂志,2004,28(1):3.
　HUANG Jian-min,FU Zhan-li,PAN Li-ping.Affect factors of the standardized uptake value for metabolic imaging with 18F-fluorine-2-deoxy-D-glucose[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):3.
[10]董爱生.18F-FDG PET在结直肠癌中的临床应用价值[J].国际放射医学核医学杂志,2004,28(1):12.
　DONG Ai-sheng.The applications of 18F-FDG PET in colorectal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):12.

备注/Memo

备注/Memo:
收稿日期:2002-08-09
作者简介:袁志斌(1969-),男,副主任技师,主要从事放射性药物和核医学影像诊断的研究。
更新日期/Last Update: 1900-01-01